The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: methylprednisolone     Quarter: 2016Q3

Total Records: 857     Number of Pages: 43

DRUGNAME PT EventCount
METHYLPREDNISOLONE. Metastases to bone 1
METHYLPREDNISOLONE. Metastases to liver 1
METHYLPREDNISOLONE. Microangiopathic haemolytic anaemia 1
METHYLPREDNISOLONE. Microsporidia infection 1
METHYLPREDNISOLONE. Monocyte percentage increased 1
METHYLPREDNISOLONE. Multiple allergies 1
METHYLPREDNISOLONE. Muscle spasms 1
METHYLPREDNISOLONE. Musculoskeletal injury 1
METHYLPREDNISOLONE. Nasal congestion 1
METHYLPREDNISOLONE. Nasal dryness 1
METHYLPREDNISOLONE. Neck pain 1
METHYLPREDNISOLONE. Necrotising fasciitis 1
METHYLPREDNISOLONE. Necrotising soft tissue infection 1
METHYLPREDNISOLONE. Nephrotic syndrome 1
METHYLPREDNISOLONE. Nerve injury 1
METHYLPREDNISOLONE. Neurological symptom 1
METHYLPREDNISOLONE. Neutrophil percentage increased 1
METHYLPREDNISOLONE. Noninfective gingivitis 1
METHYLPREDNISOLONE. Nuclear magnetic resonance imaging brain abnormal 1
METHYLPREDNISOLONE. Ocular discomfort 1

Total Records: 857     Number of Pages: 43